{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:05:15Z","timestamp":1761541515767,"version":"3.44.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010805","name":"Forskningsr\u00e5det i Syd\u00f6stra Sverige","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010805","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.thromres.2019.10.009","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T02:04:26Z","timestamp":1571709866000},"page":"136-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma \u2013 The predictive significance of B blood group"],"prefix":"10.1016","volume":"183","author":[{"given":"Menikae K.","family":"Heenkenda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Malmstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata","family":"Lysiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munila","family":"Mudaisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Bratth\u00e4ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Milos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Strandeus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"\u00c5kesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"S\u00f6derkvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivas","family":"Uppugunduri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5143-8315","authenticated-orcid":false,"given":"Abdimajid","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2019.10.009_bb0005","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0049-3848(12)70012-9","article-title":"Genetic pathways linking hemostasis and cancer","volume":"129","author":"Garnier","year":"2012","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.thromres.2019.10.009_bb0010","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/jth.13009","article-title":"Venous thrombosis and cancer: from mouse models to clinical trials","volume":"13","author":"Hisada","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.thromres.2019.10.009_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.beha.2008.12.001","article-title":"Epidemiology of cancer-related venous thromboembolism","volume":"22","author":"Wun","year":"2009","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.thromres.2019.10.009_bb0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/5584_2016_117","article-title":"Venous Thromboembolism in Brain Tumor Patients","volume":"906","author":"Jeraq","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl. 4","key":"10.1016\/j.thromres.2019.10.009_bb0025","first-page":"iv73","article-title":"Thromboembolic disease in patients with high-grade glioma","volume":"14","author":"Perry","year":"2012","journal-title":"Neuro Oncol"},{"issue":"8","key":"10.1016\/j.thromres.2019.10.009_bb0030","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1055\/s-0033-1357483","article-title":"Brain neoplasms and coagulation","volume":"39","author":"Magnus","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"10","key":"10.1016\/j.thromres.2019.10.009_bb0035","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/S0959-8049(97)00167-6","article-title":"Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective study","volume":"33","author":"Brandes","year":"1997","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.thromres.2019.10.009_bb0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11060-015-1805-2","article-title":"Venous thromboembolism (VTE) and glioblastoma","volume":"124","author":"Yust-Katz","year":"2015","journal-title":"J Neurooncol"},{"issue":"2","key":"10.1016\/j.thromres.2019.10.009_bb0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nm0296-209","article-title":"In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease","volume":"2","author":"Contrino","year":"1996","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.thromres.2019.10.009_bb0050","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm0898-909","article-title":"Thrombin receptor overexpression in malignant and physiological invasion processes","volume":"4","author":"Even-Ram","year":"1998","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.thromres.2019.10.009_bb0055","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s10930-015-9628-8","article-title":"The proteolytic profile of human cancer procoagulant suggests that it promotes cancer metastasis at the level of activation rather than degradation","volume":"34","author":"Kee","year":"2015","journal-title":"Protein J"},{"key":"10.1016\/j.thromres.2019.10.009_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.critrevonc.2017.08.003","article-title":"Mechanisms and risk factors of thrombosis in cancer","volume":"118","author":"Falanga","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.thromres.2019.10.009_bb0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1215\/15228517-2006-035","article-title":"Venous thromboembolism and survival in patients with high-grade glioma","volume":"9","author":"Simanek","year":"2007","journal-title":"Neuro Oncol"},{"issue":"10","key":"10.1016\/j.thromres.2019.10.009_bb0070","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp","year":"2013","journal-title":"Blood"},{"issue":"6475","key":"10.1016\/j.thromres.2019.10.009_bb0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.thromres.2019.10.009_bb0080","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2019.10.009_bb0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12959-016-0108-y","article-title":"Causes of venous thrombosis","volume":"14","author":"Rosendaal","year":"2016","journal-title":"Thrombosis Journal"},{"issue":"6","key":"10.1016\/j.thromres.2019.10.009_bb0090","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.thromres.2019.10.009_bb0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00277-008-0569-6","article-title":"The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis","volume":"88","author":"Eroglu","year":"2009","journal-title":"Ann Hematol"},{"issue":"13","key":"10.1016\/j.thromres.2019.10.009_bb0100","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/jnci\/djq211","article-title":"Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer","volume":"102","author":"Garber","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.thromres.2019.10.009_bb0105","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2004.05327.x","article-title":"Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients","volume":"128","author":"Kennedy","year":"2005","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.thromres.2019.10.009_bb0110","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s11033-010-0373-y","article-title":"Association of deep venous thrombosis with prothrombotic gene polymorphism identified in lung cancer cases","volume":"38","author":"Arslan","year":"2011","journal-title":"Mol Biol Rep"},{"issue":"4","key":"10.1016\/j.thromres.2019.10.009_bb0115","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/annonc\/mdp354","article-title":"Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial","volume":"21","author":"Mandala","year":"2010","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.thromres.2019.10.009_bb0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jth.12778","article-title":"Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS)","volume":"13","author":"Pabinger","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.thromres.2019.10.009_bb0125","first-page":"164","article-title":"Non-O blood group: an important genetic risk factor for venous thromboembolism","volume":"11","author":"Franchini","year":"2013","journal-title":"Blood Transfus"},{"issue":"1","key":"10.1016\/j.thromres.2019.10.009_bb0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1538-7836.2004.01071.x","article-title":"ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden","volume":"3","author":"Morelli","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"21","key":"10.1016\/j.thromres.2019.10.009_bb0135","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1182\/blood-2008-11-190389","article-title":"Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach","volume":"113","author":"Tregouet","year":"2009","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.thromres.2019.10.009_bb0140","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/CIRCULATIONAHA.115.017563","article-title":"ABO blood group and risk of thromboembolic and arterial disease: a study of 1.5 million blood donors","volume":"133","author":"Vasan","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.thromres.2019.10.009_bb0145","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.3892\/ol.2017.6619","article-title":"Association of ABO blood groups with von Willebrand factor, factor VIII and ADAMTS-13 in patients with lung cancer","volume":"14","author":"Liu","year":"2017","journal-title":"Oncol Lett"},{"issue":"3","key":"10.1016\/j.thromres.2019.10.009_bb0150","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-0037-1605564","article-title":"von Willebrand Factor and Venous Thromboembolism: pathogenic Link and Therapeutic Implications","volume":"44","author":"Calabro","year":"2018","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"10.1016\/j.thromres.2019.10.009_bb0155","first-page":"89","article-title":"factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level","volume":"37","author":"Orstavik","year":"1985","journal-title":"American Journal of Human Genetics"},{"issue":"6","key":"10.1016\/j.thromres.2019.10.009_bb0160","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/CIRCGENETICS.114.000682","article-title":"Genetic variations associated with recurrent venous thrombosis","volume":"7","author":"van Hylckama Vlieg","year":"2014","journal-title":"Circulation. Cardiovascular Genetics"},{"issue":"16","key":"10.1016\/j.thromres.2019.10.009_bb0165","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"author":"R Core Team. A Language and Environment for Statistical Computing","key":"10.1016\/j.thromres.2019.10.009_bb0170"},{"issue":"1","key":"10.1016\/j.thromres.2019.10.009_bb0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/1358863X17745591","article-title":"Factor V Leiden paradox in a middle-aged Swedish population: a prospective study","volume":"23","author":"Zoller","year":"2018","journal-title":"Vasc Med"},{"issue":"8","key":"10.1016\/j.thromres.2019.10.009_bb0180","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/cncr.20150","article-title":"ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas","volume":"100","author":"Streiff","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.thromres.2019.10.009_bb0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0049-3848(03)00179-8","article-title":"Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis","volume":"109","author":"Ramacciotti","year":"2003","journal-title":"Thromb Res"},{"issue":"3c","key":"10.1016\/j.thromres.2019.10.009_bb0190","first-page":"2561","article-title":"Are factor V and prothrombin mutations associated with increased risk of oral cancer?","volume":"25","author":"Vairaktaris","year":"2005","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.thromres.2019.10.009_bb0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3892\/br.2013.180","article-title":"Risk of prostate cancer and thrombosis-related factor polymorphisms","volume":"2","author":"Ghasemi","year":"2014","journal-title":"Biomed Rep"},{"issue":"4","key":"10.1016\/j.thromres.2019.10.009_bb0200","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/annonc\/mdh146","article-title":"Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter","volume":"15","author":"Mandala","year":"2004","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.thromres.2019.10.009_bb0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11239-006-9001-z","article-title":"Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients","volume":"23","author":"Eroglu","year":"2007","journal-title":"J Thromb Thrombolysis"},{"issue":"12","key":"10.1016\/j.thromres.2019.10.009_bb0210","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1002\/cncr.10590","article-title":"Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma","volume":"94","author":"Pihusch","year":"2002","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.thromres.2019.10.009_bb0215","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00701-018-3599-4","article-title":"Is surgical resection useful in elderly newly diagnosed glioblastoma patients? Outcome evaluation and prognostic factors assessment","volume":"160","author":"Pessina","year":"2018","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.thromres.2019.10.009_bb0220","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.wneu.2019.04.092","article-title":"Association between supratotal glioblastoma resection and patient survival: a systematic review and meta-analysis","volume":"127","author":"Incekara","year":"2019","journal-title":"World Neurosurg."},{"issue":"3","key":"10.1016\/j.thromres.2019.10.009_bb0225","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/neuonc\/noy195","article-title":"Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013","author":"Walker","year":"2019","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.thromres.2019.10.009_bb0230","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-0032-1315758","article-title":"Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature","volume":"38","author":"Dentali","year":"2012","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"10.1016\/j.thromres.2019.10.009_bb0235","first-page":"491","article-title":"Beyond immunohaematology: the role of the ABO blood group in human diseases","volume":"11","author":"Liumbruno","year":"2013","journal-title":"Blood Transfus"},{"issue":"2","key":"10.1016\/j.thromres.2019.10.009_bb0240","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02933042","article-title":"ABO blood groups and cancer of the pancreas","volume":"6","author":"Annese","year":"1990","journal-title":"Int J Pancreatol"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384819304542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384819304542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:40:27Z","timestamp":1758735627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384819304542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":48,"alternative-id":["S0049384819304542"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2019.10.009","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma \u2013 The predictive significance of B blood group","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2019.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}